Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2004-11-23
2008-10-07
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
Reexamination Certificate
active
07431914
ABSTRACT:
A contrast agent of formula I: V-L-R (I) where V is an organic group having binding affinity for an angiotensin II receptor site, L is a linear or branched amino acid-comprising biomodifier or linker moiety, and R is a reporter moiety detectable in in vivo imaging of a human or animal body.
REFERENCES:
patent: 5444069 (1995-08-01), Dudley et al.
patent: 5489425 (1996-02-01), Kruper, Jr. et al.
patent: 6264914 (2001-07-01), Klaveness et al.
patent: 7211240 (2007-05-01), Arbogast et al.
patent: 2004/0018203 (2004-01-01), Pastan et al.
patent: 98/18496 (1998-05-01), None
patent: 03/006070 (2003-01-01), None
patent: 03/006491 (2003-01-01), None
patent: 03/051859 (2003-06-01), None
patent: 2004/062568 (2004-07-01), None
patent: 2005/030266 (2005-04-01), None
Lehninger Principles of Biochemistry, 3rd edition, 2000, p. 119.
Turpin, F, et.al. “Synthesis of two novel oxocyclam-binding technetium complexes containing an analogue of cocaine” Journal of Labelled Compounds & Radipharmaceuticals, 2002, vol. 45(5), pp. 379-393 & Chemical Abstracts, abstr No. 137:225697.
Lee, H.S., et.al., “Synthesis of anion receptor grafted siloxane polymers and the ionic conductivity studies of polymer-sald complexes” Journal of the Electrochemical Society, 1999, vol. 146(3), pp. 941-946 & Chemical Abstracts, abstr. No. 130:352967.
Riche, Francoise, et.al., “Niotroimidazoles and hypoxia imaging: synthesis of three technetium-99m complexes bearing a nitroimidazole group: biological results” Bioorganic & Medicinal Chemistry Letters, 2000, Volume Date 2001, vol. 11(1), pp. 71-74 & Chemical Abstracts, abstr No. 134:202049.
GB0416062.8 Search report dated Nov. 25, 2004.
Ponchant, M. et.al. “Radiosynthesis of [tetrazoyl-11C]irbesartan, a non-peptidic angiotensin II antagonist” European Journal of Medicinal Chemistry Editions Scientifique Elsevier, Paris Fr., vol. 32, No. 9, Sep. 1997, pp. 747-752.
Burns, H.D., et.al. “Development of of [11C]L-159,884: A Radiolabelled, Nonpeptide Angiotensin II Antagonist that is Useful for Angiotensin II, At1 Receptor Imaging” Applied Radiation and Isotopes, Pergamon Press Ltd., Exeter, GB, vol. 47, No. 2, Feb. 1996, pp. 211-218.
Int'l Search Report and written opinion PCT/NO2004/000358 dated Nov. 2005.
Cuthbertson Alan
Duncanson Philip
Lovhaug Dagfinn
Powell Nigel Anthony
Solbakken Magne
Bohlken Craig
GE Healthcare AS
Hartley Michael G.
LandOfFree
Contrast agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Contrast agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Contrast agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4015803